Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/218414
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Germline genetic findings which may impact therapeutic decisions in families with a presumed predisposition for hereditary breast and ovarian cancer |
Autor: | Velázquez Pérez, Carolina; Leeneer, Kim de; Esteban Cardeñosa, Eva CSIC; Avila Cobos, Francisco; Lastra, Enrique; Abella Santos, Luis Enrique; Cruz, Virginia de la; Lobatón, Carmen D.; Claes, Kathleen B.; Durán, Mercedes CSIC ORCID; Infante, Mar CSIC ORCID | Palabras clave: | HBOC genetic testing variant prioritisation therapeutic selection Family history Clinical guidelines |
Fecha de publicación: | 3-ago-2020 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Cancers 12(8): 2151 (2020) | Resumen: | In this study, we aim to gain insight in the germline mutation spectrum of ATM, BARD1, BRIP1, ERCC4, PALB2, RAD51C and RAD51D in breast and ovarian cancer families from Spain. We have selected 180 index cases in whom a germline mutation in BRCA1 and BRCA2 was previously ruled out. The importance of disease-causing variants in these genes lies in the fact that they may have possible therapeutic implications according to clinical guidelines. All variants were assessed by combined annotation dependent depletion (CADD) for scoring their deleteriousness. In addition, we used the cancer genome interpreter to explore the implications of some variants in drug response. Finally, we compiled and evaluated the family history to assess whether carrying a pathogenic mutation was associated with age at diagnosis, tumour diversity of the pedigree and total number of cancer cases in the family. Eight unequivocal pathogenic mutations were found and another fourteen were prioritized as possible causal variants. Some of these molecular results could contribute to cancer diagnosis, treatment selection and prevention. We found a statistically significant association between tumour diversity in the family and carrying a variant with a high score predicting pathogenicity (p = 0.0003). | Versión del editor: | https://doi.org/10.3390/cancers12082151 | URI: | http://hdl.handle.net/10261/218414 | DOI: | 10.3390/cancers12082151 | E-ISSN: | 2072-6694 |
Aparece en las colecciones: | (IBGM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
germline_genetic_hereditary_ovarian_cancer.pdf | 1,6 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
4
checked on 10-abr-2024
SCOPUSTM
Citations
4
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
4
checked on 29-feb-2024
Page view(s)
104
checked on 18-abr-2024
Download(s)
76
checked on 18-abr-2024